相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic options for difficult-to-treat Acinetobacter baumanniiinfections: a 2020 perspective
Matteo Bassetti et al.
EXPERT OPINION ON PHARMACOTHERAPY (2021)
Rescuing the Last-Line Polymyxins: Achievements and Challenges
Sue C. Nang et al.
PHARMACOLOGICAL REVIEWS (2021)
The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients
Alberto E. Maraolo et al.
INFECTIOUS DISEASES AND THERAPY (2021)
Use of colistin in adult patients: A cross-sectional study
Daniele Roberto Giacobbe et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes
Amir Nutman et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Efficacy and Safety of High Loading Dose of Colistin in Multidrug-Resistant Acinetobacter baumannii: A Prospective Cohort Study
Wasan Katip et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2019)
International Consensus Guidelines for the Optimal Use of the Polymyxins Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Brian T. Tsuji et al.
PHARMACOTHERAPY (2019)
Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia
Adela Benitez-Cano et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial
Yaakov Dickstein et al.
CLINICAL INFECTIOUS DISEASES (2019)
Personalizing Polymyxin B Dosing Using an Adaptive Feedback Control Algorithm
Elizabeth A. Lakota et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
Mical Paul et al.
LANCET INFECTIOUS DISEASES (2018)
Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria
Daniele Roberto Giacobbe et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2018)
Colistin: still a lifesaver for the 21st century?
Ilias Karaiskos et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: Should we get to the PK/PD root of the paradox?
Valerio Del Bono et al.
VIRULENCE (2017)
Nebulized antibiotics in mechanically ventilated patients: roadmap and challenges
G. Poulakou et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)
Pharmacokinetic/Toxicodynamic Analysis of Colistin-Associated Acute Kidney Injury in Critically Ill Patients
Alan Forrest et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases
J. Rello et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model
Yu-Wei Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
Roger L. Nation et al.
CLINICAL INFECTIOUS DISEASES (2016)
The Effectiveness and Safety of High-Dose Colistin: Prospective Cohort Study
Yael Dishon Benattar et al.
CLINICAL INFECTIOUS DISEASES (2016)
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
Andre C. Kalil et al.
CLINICAL INFECTIOUS DISEASES (2016)
Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration
Ilias Karaiskos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Mucin Binding Reduces Colistin Antimicrobial Activity
Johnny X. Huang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients
Ilias Karaiskos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Comparison of Intrapulmonary and Systemic Pharmacokinetics of Colistin Methanesulfonate (CMS) and Colistin after Aerosol Delivery and Intravenous Administration of CMS in Critically Ill Patients
Matthieu Boisson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
Ana M. Sandri et al.
CLINICAL INFECTIOUS DISEASES (2013)
Evaluating the stability of colistin and colistin methanesulphonate in human plasma under different conditions of storage
Rajesh V. Dudhani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Structure-Activity Relationships of Polymyxin Antibiotics
Tony Velkov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
The Use of Intravenous and Aerosolized Polymyxins for the Treatment of Infections in Critically III Patients: A Review of the Recent Literature
Matthew E. Falagas et al.
CLINICAL MEDICINE & RESEARCH (2006)
Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration
J Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate
J Li et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration
J Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
分享论文
